US Stock MarketDetailed Quotes

AKBA Akebia Therapeutics

Watchlist
  • 2.0700
  • +0.1400+7.25%
Close Jan 17 16:00 ET
  • 2.0800
  • +0.0100+0.48%
Post 19:58 ET
451.64MMarket Cap-9.41P/E (TTM)

Akebia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Akebia Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 40.614M--
--2024/Q4-- / 39.023M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 40.614M--
--2024/Q4-- / 39.023M--
Nov 7, 20242024/Q337.428M / 44.505M--
Aug 8, 20242024/Q243.648M / 43.653M--
May 9, 20242024/Q132.607M / 46.087M--

Unlock Free Earnings Estimates

Akebia Therapeutics Earnings Reports

  • Akebia Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 07:18 ET

  • Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 7, 2024 07:08 ET

  • Akebia Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 07:54 ET

  • Akebia Therapeutics | 8-K: Akebia Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 8, 2024 07:09 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 10, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data